11/13
03:05 pm
arct
Rating for ARCT
Low
Report
Rating for ARCT
11/13
03:05 pm
arct
Rating for ARCT
Low
Report
Rating for ARCT
10/24
08:06 am
arct
Arcturus Therapeutics (NASDAQ:ARCT) had its "neutral" rating reaffirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock, down previously from $60.00.
Medium
Report
Arcturus Therapeutics (NASDAQ:ARCT) had its "neutral" rating reaffirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock, down previously from $60.00.
10/24
06:23 am
arct
Arcturus Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Medium
Report
Arcturus Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
10/24
06:23 am
arct
Arcturus Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Medium
Report
Arcturus Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
10/23
12:53 pm
arct
Rating for ARCT
Low
Report
Rating for ARCT
10/23
12:53 pm
arct
Rating for ARCT
Low
Report
Rating for ARCT
10/23
09:19 am
arct
Rating for ARCT
Medium
Report
Rating for ARCT
10/23
09:19 am
arct
Rating for ARCT
Medium
Report
Rating for ARCT
10/23
08:41 am
arct
Rating for ARCT
Medium
Report
Rating for ARCT
10/23
08:41 am
arct
Rating for ARCT
Medium
Report
Rating for ARCT
10/23
08:31 am
arct
Arcturus Therapeutics (NASDAQ:ARCT) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $12.00 price target on the stock.
Medium
Report
Arcturus Therapeutics (NASDAQ:ARCT) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $12.00 price target on the stock.
10/23
07:30 am
arct
Arcturus Therapeutics downgraded to Neutral from Buy at Citi
Medium
Report
Arcturus Therapeutics downgraded to Neutral from Buy at Citi
10/10
07:20 am
arct
Arcturus Therapeutics (NASDAQ:ARCT) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Arcturus Therapeutics (NASDAQ:ARCT) had its "buy" rating reaffirmed by analysts at Citigroup Inc..